Amazing interview.
Post# of 148322
I'm guessing it was done by email so that's why it's so precise and thorough. Very nice the mentioning of a need for an injectable to be long acting in order to be practical for asymptomatic NASH/NAFLD patients. Also new info that the cardiac issue with one of the two Brazil patients was due to recreational drugs.
Too bad that he didn't take over years ago but you can't change the past. Easy to see why bigger entities would be much more willing to partner with new management than with past and the only conspiracy was a conspiracy of dunces.
Still have a tough road handling the debt overhang but we definitely have a vastly more professional team on the job so the chance to turn the corner and put that all behind us probably couldn't be much better.